*Note: Name, Email and Phone Number are mandatory.

THANK YOU
Our team will get back to you shortly.
news

Africa Business Newsletter

AFRIEDGE

arrow Subscribe now arrow
Why Middle East Businesses in the Pharmaceuticals Sector Should Take Note?

#InvestInAfricaNow

26th Dec 2024
Document

Why Middle East Businesses in the Pharmaceuticals Sector Should Take Note

Africa is rapidly emerging as a logistics hub, presenting untapped opportunities for Middle Eastern investors. Positioned strategically between global markets, Africa's growing infrastructure, industrial zones, and economic reforms are turning the continent into a focal point for global supply chains. For Middle Eastern businesses, especially in the pharmaceuticals and medical sectors, Africa offers not just a market but also a platform for cost-efficient production and distribution.

Africa's location bridges trade routes between Asia, Europe, and the Americas, offering Middle Eastern businesses a significant logistical edge. With agreements such as the African Continental Free Trade Area (AfCFTA), which connects 1.4 billion people and a GDP of $3.4 trillion, Africa is fostering intra-continental trade and opening new avenues for exports.

Top 10 Opportunities in Pharmaceuticals for Middle East Investors

In the pharmaceutical and medical sectors, for instance, the Bugesera Special Economic Zone in Rwanda provides facilities tailored for manufacturing and distribution. With streamlined processes such as single-window clearance and proximity to regional markets in the East African Community (EAC) and COMESA, investors can capitalize on Africa's rising demand for affordable healthcare solutions.

Africa presents significant business opportunities for Middle East companies in the pharmaceutical sector due to its growing healthcare needs, expanding economies, and increasing government focus on health infrastructure. Here are top 10 key pharmaceutical opportunities in Africa:

Manufacturing and Production

  • Local Production: Establish pharmaceutical manufacturing plants in Africa to meet the high demand for medicines, particularly generic drugs and essential medications.
  • API Production: Invest in the production of active pharmaceutical ingredients (APIs), which are in short supply across Africa.

Distribution and Logistics

  • Regional Hubs: Leverage strategic locations to create efficient supply chain networks that ensure timely delivery of medicines across Africa.
  • Cold Chain Solutions: Provide advanced cold chain logistics for vaccines and temperature-sensitive pharmaceuticals.

Training and Capacity Building

  • Skills Development: Set up training centers to build the capacity of local healthcare professionals, pharmacists, and technicians.
  • Knowledge Transfer: Partner with universities and health institutions to share expertise in pharmaceutical manufacturing and healthcare management.

Investment in Infrastructure

  • Pharma Parks: Participate in setting up pharmaceutical industrial parks in collaboration with African governments (e.g., Glo-Djigbé Industrial Zone in Benin, and Ethiopia’s Kilinto Industrial Park).
  • Healthcare Facilities: Build hospitals, clinics, and diagnostic centers equipped with pharmaceutical services.

Generic Drug Production

  • High Demand for Generics: The demand for affordable, essential medicines to treat diseases like malaria, tuberculosis, and HIV/AIDS remains significant.
  • Import Substitution: Africa currently imports over 70% of its pharmaceuticals. Local manufacturing can reduce dependency on imports, lower costs, and improve drug accessibility.

Vaccine Manufacturing

  • High Need for Vaccines: Africa has low vaccination coverage for many diseases. Local vaccine production can address public health gaps.
  • Government and International Funding: Initiatives like the African Union’s Partnerships for African Vaccine Manufacturing (PAVM) provide support for vaccine production facilities.

Specialized Medicines and Biologics

  • Chronic Disease Treatment: Growing prevalence of non-communicable diseases (NCDs) like diabetes, hypertension, and cancer increases demand for specialized drugs.
  • Biologics and Biosimilars: Rising interest in advanced therapies and biologics, especially for cancer and autoimmune diseases.

Nutraceuticals and OTC Medicines

  • Growing Health Awareness: Increased awareness of preventative healthcare creates demand for vitamins, supplements, and over-the-counter (OTC) medications.
  • Herbal Medicines: Africa's rich biodiversity supports the development of plant-based medicines and nutraceuticals.

Supply Chain and Packaging

  • Pharmaceutical Packaging: Local production of packaging materials for drugs, reducing costs and enhancing supply chain efficiency.
  • Cold Chain Infrastructure: Manufacturing solutions for temperature-sensitive products, such as vaccines and biologics.

Diagnostics and Medical Devices

  • Diagnostic Kits: Production of affordable diagnostic kits for diseases like malaria, HIV, and COVID-19.
  • Basic Medical Devices: Manufacturing syringes, gloves, and other consumables essential for healthcare services.
Learn more about the API and medicines business opportunities in Africa >>

Focus Areas by Region

Why Africa?

Rapid Urbanization

Increasing urban population with higher disposable incomes and healthcare awareness.

Growing Health Expenditure

Governments and private sectors are increasing investments in healthcare systems.

Trade Agreements

Leverage trade agreements like the African Continental Free Trade Area (AfCFTA) to facilitate cross-border business.

Untapped Markets

Many African countries are underserved in pharmaceutical services, creating vast opportunities for new entrants.

Middle East companies can gain a competitive edge by combining their expertise in manufacturing, innovation, and logistics with Africa’s growing demand for quality healthcare solutions.

Africa's reform-driven governments and improving ease of doing business rankings add further appeal. Arise IIP’s partnership-based approach with governments ensures a transparent and supportive environment for foreign investors. For Middle Eastern businesses, this eliminates common barriers to entry and enhances operational efficiency.

Explore All Opportunities

Case Study: FHC Medica - Transforming Pharmaceutical Manufacturing in West Africa

FHC Medica established its manufacturing plant within the Arise IIP’s Industrial Zones in Togo and Benin. The partnership between FHC Medica and Arise IIP has been instrumental in supporting the company’s operations and growth in West Africa.

Key Solutions Provided by Arise IIP:

  • Land Lease: Secured land for establishing the manufacturing plant.
  • Infrastructure Support: Reliable 24x7 electricity and clean running water.
  • Spread Management: Efficient land use planning for optimal factory operations.
  • Workforce Training: Ensured skilled labor through comprehensive training programs.
  • Activity Monitoring: Regular monitoring of operations to maintain quality and efficiency.
  • Wastewater Management: Implemented sustainable solutions for managing industrial waste.

"Collaboration with Arise IIP has been a wonderful, transformative experience. Their expertise and tailored solutions have greatly improved our efficiency and bottom line. We are excited about our continued partnership." — FHC Medica

Read more about the FHC Medica case study here >>

The Role of Arise IIP

ARISE IIP (Arise Integrated Industrial Platforms) plays a pivotal role in Africa's industrial transformation. By developing world-class industrial zones with cutting-edge infrastructure, Arise IIP facilitates seamless business operations. For Middle Eastern investors, Arise IIP’s industrial parks in countries like Rwanda, Benin, Togo, Ivory Coast, Nigeria, Democratic Republic of Congo and Chad offer the ideal environment to establish and grow their businesses.

Africa’s transformation into a logistics hub offers Middle Eastern investors an unprecedented opportunity to expand their global footprint. With Arise IIP’s industrial zones providing the foundation for success, sectors like pharmaceuticals, medical manufacturing, and waste management stand to benefit immensely. The time is now for Middle Eastern investors to take note of Africa’s potential and establish their presence in the continent poised to become the logistics hub of tomorrow.

Interested in setting up your

pharmaceutial business in Africa?

For business enquiries from Middle East, please call on
+971 58 932 1577

Invest Now >>

Our Partners

close_download_form

africa is inviting investors

download AFI investor reports & documents

WANT TO STAY CONNECTED WITH
AFRICA FOR INVESTORS?
Sign-up for our newsletters
EXPLORE MORE INSIGHTS
Unveiling Africa’s Manufacturing Industry: Opportunities Await!

Africa For Investors | 4th Oct 2024

Unveiling Africa’s Manufacturing Industry: Opportunities Await!

AfriEdge Newsletter: Monthly News Roundup Aug'24 Edition

Africa For Investors | 4th Sep 2024

AfriEdge Newsletter: Monthly News Roundup Aug'24 Edition

AfriEdge: Business Insights Edition 1

Africa For Investors | 2nd Dec 2024

AfriEdge: Business Insights Edition 1

Capitalize in Africa's Growth Today

Africa For Investors | 30th Oct 2024

Capitalize in Africa's Growth Today

Full Screen Image
Double click to close

Compare

img_alt Remove all

Dear investor, please compare similar category items- either Locations or Opportunities.

 closs icon
close

*Already subscribed.

*Enter your name/email.

arise logo

Don’t Miss Out on Africa's Biggest Investment Opportunities!

Sign up for exclusive investment alerts.

Already subscribed? Skip

Thank You For Subscribing to

Africa For Investors.

submit icons

Stay On AFI Website